J F Garvey1, P Gueret, T J McDonnell. 1. Department of Respiratory Medicine, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland. john.garvey@ucd.ie
Abstract
BACKGROUND: The Bacille-Calmette-Guérin (BCG) vaccine is used in Mycobacterium tuberculosis prophylaxis in at risk tuberculin-negative healthcare workers. Its use is contraindicated however in individuals with HIV infection. AIMS: We herein highlight the case of a healthcare worker who developed a localised reaction at a BCG vaccination site and who was subsequently found to be HIV positive. CONCLUSION: This case emphasises the importance of eliciting risk factors for immunocompromise in individuals for whom BCG vaccination is being considered.
BACKGROUND: The Bacille-Calmette-Guérin (BCG) vaccine is used in Mycobacterium tuberculosis prophylaxis in at risk tuberculin-negative healthcare workers. Its use is contraindicated however in individuals with HIV infection. AIMS: We herein highlight the case of a healthcare worker who developed a localised reaction at a BCG vaccination site and who was subsequently found to be HIV positive. CONCLUSION: This case emphasises the importance of eliciting risk factors for immunocompromise in individuals for whom BCG vaccination is being considered.
Authors: Mark Hatherill; Thomas J Scriba; Zarir F Udwadia; Jai B Mullerpattan; Anthony Hawkridge; Hassan Mahomed; Christopher Dye Journal: Clin Infect Dis Date: 2016-05-15 Impact factor: 9.079